Women and girls’ lives are being lost due to the abrupt and sweeping cancellation of U.S. assistance approved by Congress.

More traditional COVID vaccines (vector viral) like the one developed by Johnson & Johnson and Oxford-AstraZeneca were associated with more statistically significant increases in rare adverse ...

Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple myeloma, after reporting that it met its objectives in a phase 3 trial.

GT005 is a one-shot therapy which aims to treat GA by delivering the gene for complement factor I (CFI) to the eye using an adeno-associated virus (AAV) vector. CFI regulates the activity of the ...

After taking credit for Operation Warp Speed, which quickly funded the development of the Pfizer, Moderna, and Johnson & Johnson vaccines ... you’d no longer be a vector for the coronavirus.

Johnson & Johnson and Merck are laying off employees in China ... facility in Plainville provides viral vector services ranging from process development to commercial manufacturing. Charles River ...

That said, one stock that continues to stand out is Johnson & Johnson JNJ. The pharmaceutical giant's stock hit new 52-week highs of nearly $170 on Tuesday, with JNJ now up +16% year to date.

Johnson & Johnson’s biggest strength is its diversified business model. It operates through pharmaceuticals and medical devices divisions. It has more than 275 subsidiaries, which clearly means ...